Journal of Jilin University(Medicine Edition) ›› 2020, Vol. 46 ›› Issue (03): 662-667.doi: 10.13481/j.1671-587x.20200338
• Review • Previous Articles
Research progress in circulating tumor cells as a new generation of tumor marker
-
Received:2019-07-15Online:2020-05-28Published:2020-06-11
CLC Number:
- R73
Cite this article
share this article
| [1] 李健斌, 江泽飞. 循环肿瘤细胞研究进展:从计数到表型的转变[J].中华肿瘤杂志, 2016, 38(12):881-885. [2] CHAFFER C L, SAN JUAN B P, LIM E, et al. EMT, cell plasticity and metastasis[J]. Cancer Metastasis Rev, 2016, 35(4):645-654. [3] MARRINUCCI D, BETHEL K, BRUCE R H, et al. Case study of the morphologic variation of circulating tumor cells[J]. Hum Pathol, 2007, 38(3):514-519. [4] CHEUNG K J, EWALD A J. A collective route to metastasis:Seeding by tumor cell clusters[J]. Science, 2016, 352(6282):167-169. [5] SKUBITZ A P, TARAS E P, BOYLAN K L, et al. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression[J]. Gynecol Oncol, 2013, 130(3):579-587. [6] MAO S F, ZHANG Q, LI H F, et al. Adhesion analysis of single circulating tumor cells on a base layer of endothelial cells using open microfluidics[J]. Chem Sci, 2018, 9(39):7694-7699. [7] KROG B L, HENRY M D. Biomechanics of the circulating tumor cell microenvironment[J]. Adv Exp Med Biol, 2018, 1092:209-233. [8] LIBERKO M, KOLOSTOVA K, BOBEK V. Essentials of circulating tumor cells for clinical research and practice[J]. Crit Rev Oncol Hematol, 2013, 88(2):338-356. [9] SOLER A, CAYREFOURCQ L, MAZARD T, et al. Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes[J]. Sci Rep, 2018, 8(1):15931. [10] FABISIEWICZ A, GRZYBOWSKA E. CTC clusters in cancer progression and metastasis[J]. Med Oncol, 2017, 34(1):12. [11] VAN ES N, STURK A, MIDDELDORP S, et al. Effects of cancer on platelets[J]. Semin Oncol, 2014, 41(3):311-318. [12] AMIRKHOSRAVI A, MOUSA S A, AMAYA M, et al. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpⅡb/Ⅲa antagonist XV454[J]. Thromb Haemost, 2003, 90(3):549-554. [13] FELDING-HABERMANN B, HABERMANN R, SALDIVAR E, et al. Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow[J]. J Biol Chem, 1996, 271(10):5892-5900. [14] YIE S M, LUO B, YE N Y, et al. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA[J]. Clin Exp Metastasis, 2006, 23(5/6):279-289. [15] VEGRAN F, BOIDOT R. Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells[J]. Oncoimmunology, 2013, 2(11):e26328. [16] SAKAGUCHI S, YAMAGUCHI T, NOMURA T, et al. Regulatory T cells and immune tolerance[J]. Cell, 2008, 133(5):775-787. [17] CHOI J, SUH B, AHN Y O, et al. CD15+/CD16 low human granulocytes from terminal cancer patients:granulocytic myeloid-derived suppressor cells that have suppressive function[J]. Tumour Biol, 2012, 33(1):121-129. [18] XU J M, ZHANG Y, JIA R, et al. Anti-PD-1 antibody SHR-1210 combined with apatinib for advanced hepatocellular carcinoma, gastric, or esophagogastric junction cancer:an open-label, dose escalation and expansion study[J]. Clin Cancer Res, 2019, 25(2):515-523. [19] GASCOYNE P R, NOSHARI J, ANDERSON T J, et al. Isolation of rare cells from cell mixtures by dielectrophoresis[J]. Electrophoresis, 2009, 30(8):1388-1398. [20] LIU Z X, GUO W X, ZHANG D D, et al. Circulating tumor cell detection in hepatocellular carcinoma based on karyoplasmic ratios using imaging flow cytometry[J]. Sci Rep, 2016, 6:39808. [21] HAROUAKA R A, ZHOU M D, YEH Y T, et al. Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells[J]. Clin Chem, 2014, 60(2):323-333. [22] SARIOGLU A F, ACETO N, KOJIC N, et al. A microfluidic device for label-free, physical capture of circulating tumor cell clusters[J]. Nat Methods, 2015, 12(7):685-691. [23] CHEN L J, PENG M, LI N, et al. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer[J]. Sci Rep, 2018, 8(1):1188. [24] ZHANG Y J, WANG F, NING N, et al. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer[J]. Int J Cancer, 2015, 136(5):1228-1233. [25] GOODALE D, PHAY C, POSTENKA C O, et al. Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry[J]. Cytometry A, 2009, 75(4):344-355. [26] ANDREE K C, VAN DALUM G, TERSTAPPEN L W. Challenges in circulating tumor cell detection by the cell search system[J]. Mol Oncol, 2016, 10(3):395-407. [27] SEQUIST L V, NAGRATH S, TONER M, et al. The CTC-chip:an exciting new tool to detect circulating tumor cells in lung cancer patients[J]. J Thorac Oncol, 2009, 4(3):281-283. [28] STUTTERHEIM J, ICHOU F A, DEN OUDEN E, et al. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma[J]. Clin Cancer Res, 2012, 18(3):808-814. [29] EBERWINE J, SUL J Y, BARTFAI T, et al. The promise of single-cell sequencing[J]. Nat Methods, 2014, 11(1):25-27. [30] RAGHUNATHAN A, FERGUSON H R, BORNARTH C J, et al. Genomic DNA amplification from a single bacterium[J]. Appl Environ Microbiol, 2005, 71(6):3342-3347. [31] ZONG C H, LU S J, CHAPMAN A R, et al. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell[J]. Science, 2012, 338(6114):1622-1626. [32] JIANG R Z, LU Y T, HO H, et al. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer[J]. Oncotarget, 2015, 6(42):44781-44793. [33] GAO Y Y, ZHU YY, ZHANG Z Z, et al. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization[J]. J Exp Clin Cancer Res, 2016, 35:66. [34] ILIE M, HOFMAN V, LONG-MIRA E, et al. "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease[J]. PLoS One, 2014, 9(10):e111597. [35] CHEN X X, ZHOU F, LI X F, et al. Folate receptor-positive circulating tumor cell detected by lt-pcr-based method as a diagnostic biomarker for non-small-cell lung cancer[J]. J Thorac Oncol, 2015, 10(8):1163-1171. [36] NAITO T, TANAKA F, ONO A, et al. Prognostic impact of circulating tumor cells in patients with small cell lung cancer[J]. J Thorac Oncol, 2012, 7(3):512-519. [37] ANKENY J S, COURT C M, HOU S, et al. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer[J]. Br J Cancer, 2016, 114(12):1367-1375. [38] QIAO G L, QI W X, JIANG W H, et al. Prognostic significance of circulating tumor cells in esophageal carcinoma:a meta-analysis[J]. Oncol Targets Ther, 2016, 9:1889-1897. [39] HELLER G, MCCORMACK R, KHEOH T, et al. Circulating tumor cell number as a response measure of prolonged survival for metastatic castration-resistant prostate cancer:a comparison with prostate-specific antigen across five randomized phase Ⅲ clinical trials[J]. J Clin Oncol, 2018, 36(6):572-580. [40] SHIMAZU K, FUKUDA K, YOSHIDA T, et al. High circulating tumor cell concentrations in a specific subtype of gastric cancer with diffuse bone metastasis at diagnosis[J]. World J Gastroenterol, 2016, 22(26):6083-6088. [41] GEMENETZIS G, GROOT V P, YU J, et al. Circulating tumor cells dynamics in pancreatic adenocarcinoma correlate with disease status:results of the prospective CLUSTER study[J]. Ann Surg, 2018, 268(3):408-420. [42] SHEN J Q, ZHAO J, JIANG T, et al. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy[J]. Oncotarget, 2017, 8(30):49044-49052. [43] CHEN J F, HO H, LICHTERMAN J, et al. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases[J]. Cancer, 2015, 121(18):3240-3251. [44] DE BONO J S, SCHER H I, MONTGOMERY R B, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer[J]. Clin Cancer Res, 2008, 14(19):6302-6309. [45] SPARANO J, O'NEILL A, ALPAUGH K, et al. Association of circulating tumor cells with late recurrence of estrogen receptor-positive breast cancer:a secondary analysis of a randomized clinical trial[J]. JAMA Oncol, 2018, 4(12):1700-1706. [46] PAPADAKI M A, STOUPIS G, THEODOROPOULOS P A, et al. Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer[J]. Mol Cancer Ther, 2019, 18(2):437-447. [47] SHEN J, WANG W S, ZHU X L, et al. High epithelial cell adhesion molecule-positive circulating tumor cell count predicts poor survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization[J]. J Vasc Interv Radiol, 2018, 29(12):1678-1684. [48] PANTEL K, ALIX-PANABIERES C. Functional studies on viable circulating tumor cells[J]. Clin Chem, 2016, 62(2):328-334. [49] PESTRIN M, BESSI S, PUGLISI F, et al. Final results of a multicenter phase Ⅱ clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study[J]. Breast Cancer Res Treat, 2012, 134(1):283-289. [50] PACHMANN K, SCHUSTER S. The value of monitoring the behavior of circulating tumor cells at the end of endocrine therapy in breast cancer patients[J]. Cancers (Basel), 2018, 10(11):E407. [51] GOODMAN C R, SEAGLE B L, FRIEDL T W P, et al. Association of circulating tumor cell status with benefit of radiotherapy and survival in early-stage breast cancer[J]. JAMA Oncol, 2018, 4(8):e180163. [52] SCHER H I, GRAF R P, SCHREIBER N A, et al. Assessment of the validity of nuclear-localized androgen receptor splice variant 7 in circulating tumor cells as a predictive biomarker for castration-resistant prostate cancer[J]. JAMA Oncol, 2018, 4(9):1179-1186. |
| [1] | Lina ZHANG,Zhesi MENG,Long BA,Jun MENG. Research progress in relationship between cell division cycle protein 6 and occurrence and development of tumor [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 847-853. |
| [2] | Zhipeng PAN,Le WANG,Weiwen HUANG,Zhen YI,Yuxuan GAO. Bioinformatics analysis and experimental validation based on screening and identification of diagnostic candidate genes of bone marrow mononuclear cells of acute myeloid leukemia patients and their impact on prognosis [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 791-805. |
| [3] | Xiaohui LIANG,Wenna LIU,Jianbo ZHAO. Bioinformatic analysis on PAQR3 expression in hepatocellular carcinoma and its correlations with T lymphocyte infiltration, immune checkpoint genes, and patient survival [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 781-790. |
| [4] | Gengfei CAO, SHAYA·Mahati,Junpeng GU,Weizheng JI, ASIHAER·Hasimu,Weixin REN. Differences in immune microenvironment between DEB-TACE and c-TACE in treatment of hepatocellular carcinoma and mechanism of TRADD-mediated Th17 differentiation [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 764-780. |
| [5] | Xin LIU,Yuyang ZHANG,Deling ZENG,Xiaoqin LIU,Lu ZHANG,Meiying LI,Hong CHEN,Bangrong CAO,Shiqi MA. Levels of KLRG1 +NK cells in peripheral blood of NSCLC patients and their clinical significances [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 746-754. |
| [6] | Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745. |
| [7] | Heqiang JIA,Lu PAN,Zhenjiang WANG,Jiayu LU,Dan WANG,Lifeng LIU,Ying DONG,Chunyan YU. Improving effect of Panaxatriol saponins on D-galactose-induced skeletal muscle aging of mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 730-737. |
| [8] | Yang LI,Shiyang LI,Hongmei ZHANG,Qianqian LIU,Yubing CHEN. Effect of NGFR gene expression differences on promotion of apoptosis of squamous cell carcinoma and adenocarcinoma cells by PD-1 inhibitor-activated T lymphocytes [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 680-693. |
| [9] | Xiao ZHOU,Haitao DAI,Yunshan DING,Linjie ZHANG,Nan WU. Network pharmacology analysis and in vitro experimental validation of anticancer effect of grape seed proanthocyanidins against oral squamous cell carcinoma [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 651-662. |
| [10] | Wei ZHOU,Yangyang HE,Youde WANG,Wenzhuo MA,Heng KANG. Effect of histone deacetylase 6 inhibitor ACY-241 on macrophage polarization and biological behaviors of esophageal cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 621-632. |
| [11] | Jie YU,Zongkang WANG,Xun LIU,Yanan YANG,Jin TAN. Effect of miR-153-3p/PGC-1α axis on apoptosis of oral squamous cell carcinoma cells by modulation of mitochondrial apoptosis pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 348-358. |
| [12] | Yao ZHENG,Mingxia FU,Weichen WANG,Weiwei CHEN,Yuchen HAN,Yu BAI,Jiajia AN. Effect of sodium selenite on biological behaviors of breast cancer doxorubicin-resistant MCF-7/ADR cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 410-417. |
| [13] | Yu ZHAO,Xiaoshuang HE,Xiaoyin DONG,Fengyi GAO,Jiageng HE. Regulatory effect of lncRNA urothelial carcinoembryonic antigen 1 on anoikis in human gastrointestinal stromal tumor cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 429-439. |
| [14] | Li ZHAI,Meng CHEN,Jianbo LUO,Aili ZHANG,Liangxiao WANG,Ying WEI,Xi ZHANG. Targeting relationship between miR-214-3p and EZH2 and its effects on proliferation， invasion， and apoptosis of ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 460-468. |
| [15] | Hong LI,Panpan YU,Zouyu ZHAO,Chongfeng SUN,Hui QIAO,Ping YANG. Expression of GSTO1 in ovarian cancer tissue and effect of N-glycosylation site mutations on biological behaviors of epithelial ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 469-482. |